Intermittent preventive treatment in pregnancy with sulfadoxine–pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana

[1]  E. Owusu-Dabo,et al.  Intermittent preventive treatment comparing two versus three doses of sulphadoxine pyrimethamine (IPTp-SP) in the prevention of anaemia in pregnancy in Ghana: A cross-sectional study , 2021, PloS one.

[2]  M. Glymour,et al.  Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis , 2020, The Lancet. Global health.

[3]  P. Houzé,et al.  Effect of Drug Pressure on Promoting the Emergence of Antimalarial-Resistant Parasites among Pregnant Women in Ghana , 2020, Antimicrobial Agents and Chemotherapy.

[4]  Isaac Buabeng,et al.  Uptake of intermittent preventive treatment in pregnancy for malaria: further analysis of the 2016 Ghana Malaria Indicator Survey , 2020, Journal of Public Health.

[5]  A. Laar,et al.  High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana , 2019, Scientific Reports.

[6]  J. Ribeiro,et al.  Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains , 2019, Communications Biology.

[7]  A. Oduro,et al.  Intermittent Preventive Treatment of Malaria in Pregnancy: Assessment of the Sulfadoxine-Pyrimethamine Three-Dose Policy on Birth Outcomes in Rural Northern Ghana , 2019, Journal of tropical medicine.

[8]  Felix Boakye Oppong,et al.  Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015 , 2019, BMJ Open.

[9]  F. Anto,et al.  Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana , 2017, Malaria Journal.

[10]  D. Chandramohan,et al.  Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Walker,et al.  Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model , 2017, PLoS medicine.

[12]  B. Chi,et al.  Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region. , 2017, The American journal of tropical medicine and hygiene.

[13]  Who Malaria Policy Advisory Committee and Secretariat.  Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015) , 2016, Malaria Journal.

[14]  Steve M. Taylor,et al.  Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  F. Binka,et al.  Effect of a Malaria Control Program on the Prevalence of Malaria, Fever and Anaemia in Children under Five Years in the Hohoe Municipality of Ghana: A Comparative Analysis of Cross-Sectional Surveys , 2015 .

[16]  S. Escolano,et al.  Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability. , 2015, The American journal of tropical medicine and hygiene.

[17]  Steve M. Taylor,et al.  The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women. , 2015, The Journal of infectious diseases.

[18]  A. Dosani,et al.  Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania , 2014, Malaria Journal.

[19]  Steve M. Taylor,et al.  A Quality Control Program within a Clinical Trial Consortium for PCR Protocols To Detect Plasmodium Species , 2014, Journal of Clinical Microbiology.

[20]  M. Alifrangis,et al.  High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin , 2013, Malaria Journal.

[21]  O. Doumbo,et al.  Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. , 2013, JAMA.

[22]  Steve M. Taylor,et al.  Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria , 2013, Tropical medicine & international health : TM & IH.

[23]  A. Bennett,et al.  Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. , 2012, The Lancet. Infectious diseases.

[24]  O. Doumbo,et al.  Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  N. White.  Open access, freely available online Policy Forum Intermittent Presumptive Treatment for Malaria A better understanding of the pharmacodynamics will guide more rational policymaking , 2022 .

[26]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[27]  C. Drakeley,et al.  Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania , 2003, Antimicrobial Agents and Chemotherapy.

[28]  Leo Goodstadt,et al.  CHROMA: consensus-based colouring of multiple alignments for publication , 2001, Bioinform..

[29]  O. Doumbo,et al.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.

[30]  E. N. Odjidja,et al.  Low Uptake of Intermittent Preventive Treatment in Ghana; An Examination of Health System Bottlenecks , 2017 .

[31]  Mary Mungai,et al.  Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. , 2005, The Journal of infectious diseases.

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..